| Adverse effects of opioids on the central nervous systems of palliative care patients J Vella-Brincat, AD Macleod Journal of pain & palliative care pharmacotherapy 21 (1), 15-25, 2007 | 162 | 2007 |
| Haloperidol in palliative care J Vella-Brincat, AD Macleod Palliative medicine 18 (3), 195-201, 2004 | 108 | 2004 |
| Protein binding of cefazolin is saturable in vivo both between and within patients JWA Vella‐Brincat, EJ Begg, CMJ Kirkpatrick, M Zhang, ST Chambers, ... British journal of clinical pharmacology 63 (6), 753-757, 2007 | 75 | 2007 |
| Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit JWA Vella-Brincat, EJ Begg, BJ Robertshawe, AM Lynn, TL Borrie, ... Neonatology 100 (2), 186-193, 2011 | 60 | 2011 |
| Stability of benzylpenicillin during continuous home intravenous therapy JWA Vella-Brincat, EJ Begg, K Gallagher, CMJ Kirkpatrick, M Zhang, ... Journal of Antimicrobial Chemotherapy 53 (4), 675-677, 2004 | 43 | 2004 |
| Withdrawal with transdermal fentanyl CMB HIGGS, J Vella-Brincat Journal of pain and symptom management 10 (1), 4-5, 1995 | 38 | 1995 |
| Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates EJ Begg, JWA Vella-Brincat, B Robertshawe, MJ McMurtrie, ... Journal of antimicrobial chemotherapy 63 (5), 1043-1049, 2009 | 28 | 2009 |
| Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin SM Plajer, PKL Chin, JWA Vella-Brincat, PJ Buffery, EJ Begg Therapeutic drug monitoring 37 (1), 98-103, 2015 | 24 | 2015 |
| Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles? PKL Chin, JWA Vella-Brincat, ML Barclay, EJ Begg British journal of clinical pharmacology 74 (5), 734, 2012 | 22 | 2012 |
| Pharmacovigilance in hospice/palliative care: rapid report of net clinical effect of metoclopramide DC Currow, J Vella-Brincat, B Fazekas, K Clark, M Doogue, D Rowett Journal of palliative medicine 15 (10), 1071-1075, 2012 | 22 | 2012 |
| Cefazolin plasma protein binding in different human populations: more than cefazolin-albumin interaction. A Smits, JA Roberts, JWA Vella-Brincat, K Allegaert | 20 | 2014 |
| Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital PKL Chin, JWA Vella‐Brincat, SL Walker, ML Barclay, EJ Begg Internal Medicine Journal 43 (7), 778-783, 2013 | 20 | 2013 |
| Prescribing and monitoring clozapine in Christchurch A McKean, J Vella-Brincat, E Begg Australasian Psychiatry 16 (4), 263-267, 2008 | 17 | 2008 |
| Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion GW Howard, EJ Begg, ST Chambers, J Vella Brincat, M Zhang, ... Journal of Antimicrobial Chemotherapy 50 (3), 429-432, 2002 | 17 | 2002 |
| Swallowing capsules AD MacLeod, J Vella-Brincat, C Frampton Palliative Medicine 17 (6), 559-559, 2003 | 16 | 2003 |
| Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS) BP Jensen, JWA Vella-Brincat, EJ Begg Journal of Chromatography B 879 (9-10), 605-609, 2011 | 12 | 2011 |
| The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patients JWA Vella-Brincat, EJ Begg, BP Jensen, PKL Chin, RL Roberts, ... Journal of pain and symptom management 43 (3), 540-548, 2012 | 11 | 2012 |
| Ten-year dispensing trends of hypnotics in New Zealand A McKean, J Vella-Brincat The New Zealand Medical Journal (Online) 124 (1331), 2011 | 9 | 2011 |
| Exploring hospice patients’ views about participating in research M Fairhall, K Reid, JWA Vella-Brincat, J Walker, PKL Chin, BP Jensen, ... Journal of Pain and Symptom Management 43 (3), e9-e11, 2012 | 8 | 2012 |
| Terminal restlessness–is it a fair clinical concept AD Macleod, J Vella-Brincat, M Topp Eur J Palliat Care 11, 188-9, 2004 | 8 | 2004 |
